指導教授 ︰ 周碧瑟教授 、 蔡世澤醫師 研究生 ︰ 吳秀英

Click here to load reader

download 指導教授 ︰ 周碧瑟教授 、 蔡世澤醫師 研究生 ︰ 吳秀英

of 31

description

金門地區以代謝症候群預測全死因及心血管疾病死亡率之研究 Components of Metabolic Syndrome as Predictors of Total and Cardiovascular Disease Mortality─ Kinmen study. 指導教授 ︰ 周碧瑟教授 、 蔡世澤醫師 研究生 ︰ 吳秀英. 前言. 死亡率 ︰92 年十大死因的第四位,死亡率二十年上升 3.8 倍 盛行率 ︰40 歲以上民眾約為 11-13% 發生率 ︰ 竹東朴子 35-74 歲一般族群粗發生率約 9.0 -9.8/1,000 - PowerPoint PPT Presentation

Transcript of 指導教授 ︰ 周碧瑟教授 、 蔡世澤醫師 研究生 ︰ 吳秀英

  • Components of Metabolic Syndrome as Predictors of Total and Cardiovascular Disease Mortality Kinmen study

  • 923.8

    4011-13%

    35-749.0 -9.8/1,000

    4%6%(1998)

    19986.2%

  • 1923

    1988ReavenSyndrome X(Metabolic Syndrome, MS)

  • (MS)1998WHO (1999BP160/90140/90mmHg)

    2001National Cholesterol Education Program Adult Treatment Panel (NCEP/ATP )

    1999The European Group for the study of Insulin Resistance (EGIR) (p.6) MSmorbiditymortality (components of MS, no. of abnormalities)

  • DM,HPBMIWHRTGChol.HDLSBPDBPHbA1cinsulin

    Wang YY (2004)MSWBC, RBC (RBC, WBC MS3-4)Lin RT (2004) (non-DM+CADMS52%non-DM+non-CADMS19%)Chuang SY (2002)MSChien KL (1999)high LDL_Clow HDL_C

  • MSmortality

    1976-92,NHANES II(925230-7513.5)MSCVD(OR=1.2)CHD(OR=1.7)(OR=1.2)

    1978-87, (41,05620-697)MSCVDHazard ratio(1,2,3,4,5HR11.21.41.82)

    1984-89,(120942-6011.6)ATP IIIMSCHD(RR=4.3) CVA(RR=2.3)(RR=1.7)

  • ()MS()MS()MS()MS()MS()

  • 1991-9312,49030

    1991-95 1996-01

    1997DMHP

    9,117 ()

  • MS HDL-CTg()

    () (DM=32)

    logistic regressionC statistic

    > =3

  • C Haffner et al (69) 95 mmHg / 58.565.0Liese et al (71)/ 140/90 mmHg/ 62.967.7Cook et al (44)90 percentile(160/97.4 mmHg)58.263.4Wilson et al (54) (quintile)( 148 mmHg 146.7 mmHg)61.567.4

    Chen et al (73)

    (quartile)( 144/90.7 mmHg 140.7/86.7 mmHg )61.467.6

  • ATP III

  • MS MS 5. MS

  • 1.

    Chart1

    26.8423.5

    24.4223.24

    20.5227.27

    17.5217.25

    10.718.74

    Sheet1

    P

    No.%No.%No.%

    30-39230525.28130826.899723.5

  • > > >CVD+DM > CVD > CHD

    Chart3

    10.966.78

    3.551.63

    2.912.75

    2.592.22

    0.440.23

    Sheet1

    10.966.78

    3.551.63

    CVD+DM2.912.75

    CVD2.592.22

    CHD0.440.23

    Sheet1

    Sheet2

    Sheet3

  • 2. MS

  • MS MS
  • MS > > >Tg > HDL-C ATP III: > =Tg > > HDL-C

    Chart1

    1.471.52

    1.681.45

    1.061.07

    1.371.44

    1.411.16

    ATP III

    OR

    Sheet1

    ATP III

    1.471.52

    1.681.45

    HDL_C1.061.07

    TG1.371.44

    1.411.16

    Sheet1

    00

    00

    00

    00

    00

    ATP III

    OR

    Sheet2

    Sheet3

  • 3. MS

  • MS

    OR

    Chart3

    1.261.21

    1.651.42

    2.031.41

    32.07

    ATP III

    multivariate-adjusted OR

    Sheet1

    123>=4

    1.261.652.033

    ATP III1.211.421.412.07

    Sheet1

    ATP III

    Number of MS disorders

    multivariate-adjusted OR

    Sheet2

    Sheet3

  • 4. MS

  • ATP III

  • 50 MSC

  • 50MS50140/90 mmHg98 cm

    3.5

  • 140/90 mmHg98 cm

    1/2premature death

  • >= 140/85 mmHg>=98 cm(45%) >= 140/85 mmHg>=98 cm(87%)

    10,000(50+120)*10,000 =1,700,000

    1.5509(55%)5509(50+120)*5509=936,53055%(936,530/1,700,000=55%)

    2.1,340 (13.4%)(50+120)*1340=227,80013.4%

  • 12372.4%

  • ATP MSMSCHD(OR=2.8) (OR=2.3) OR=1.7MS(OR=1.7) (OR=1.5) (OR=1.4)(0=4.41=9.02=14.63=19.04=31.1)MS3(OR: 0=11=1.32=1.73=2.04=3)

  • s06